Systematic in-vitro evaluation of the NCI/NIH developmental therapeutics program approved oncology drug set for the identification of a candidate drug repertoire for MLL-rearranged leukemia
Kimberley A. Hoeksema, Aarthi Jayanthan, Todd Cooper, Lia Gore, Tanya Trippett, Jessica Boklan, Robert J. Arceci, Aru Narendran
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Systematic in-vitro evaluation of the NCI/NIH developmental therapeutics program approved oncology drug set for the identification of a candidate drug repertoire for MLL-rearranged leukemia'. Together they form a unique fingerprint.